Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers
Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets
Complementary Capabilities Range from API Manufacturing through Process Development and cGMP Manufacturing to Fill/Finish
Related news for (SCTL)
- Societal CDMO Reports Inducement Grants for New Staff
- Societal CDMO Reports Third Quarter 2023 Financial Results
- Societal CDMO Enters Agreement With Atossa Therapeutics to Provide Clinical Trial Services (CTS) for Innovative Selective Estrogen Receptor Modulator
- Societal CDMO Reports Inducement Grants for New Staff